Search
for
Sort by
Research 61–90 of 995
- Melatonin Receptors and Their Role in Human Diseases
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Defining dermal adipose tissue
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome
- Androgen receptor gene polymorphism and biological age markers in men
- Workup and Management of Polycystic Ovary Syndrome
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Is dehydroepiandrosterone a hormone?
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Debatable Topics in PCOS Patients
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung